Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2013 June;61(3) > Minerva Cardioangiologica 2013 June;61(3):263-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

  INTERVENTIONAL INNOVATIONS: NOVEL THERAPIES AND THE BEST NEW DEVICE CONCEPTS FOR 2013


Minerva Cardioangiologica 2013 June;61(3):263-9

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

New St. Jude Medical Portico™ transcatheter aortic valve: features and early results

Spence M. S. 1, Lyons K. 1, Mcverry F. 2, Smith B. 1, Manoharan G. B. 1, Maguire C. 1, Doherty R. 1, Anderson L. 1, Morton A. 1, Hughes S. 2, Hoeritzauer I. 2, Manoharan G. 1

1 Belfast Heart Centre, Royal Victoria Hospital, Belfast Trust, Belfast, UK; 2 Department of Neurology, Royal Victoria Hospital, Belfast Trust, Belfast, UK


PDF  


Patients with symptomatic aortic valve disease who are inoperable or have high surgery-related risks may be treated with transcatheter aortic valve implantation devices. With this method increasingly applied, device innovations are aimed at achieving improved procedural results and therapeutic outcome. This paper describes the innovations implemented in the St. Jude Medical Portico™ system for transcatheter aortic valve implantation, the application of this system and initial clinical experience.

top of page

Publication History

Cite this article as

Corresponding author e-mail

markspence1@yahoo.co.uk